Novo Integrated Sciences Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $0.3527
- Today's High:
- $0.4283
- Open Price:
- $0.3741
- 52W Low:
- $0.069
- 52W High:
- $1.418
- Prev. Close:
- $0.366
- Volume:
- 84273355
Company Statistics
- Market Cap.:
- $57.68 million
- Book Value:
- 0.183
- Revenue TTM:
- $1.12 million
- Operating Margin TTM:
- -921.86%
- Gross Profit TTM:
- $3.82 million
- Profit Margin:
- 0%
- Return on Assets TTM:
- -12.04%
- Return on Equity TTM:
- -92.43%
Company Profile
Novo Integrated Sciences Inc had its IPO on 2017-09-22 under the ticker symbol NVOS.
The company operates in the Healthcare sector and Medical Care Facilities industry. Novo Integrated Sciences Inc has a staff strength of 115 employees.
Stock update
Shares of Novo Integrated Sciences Inc opened at $0.37 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0.35 - $0.43, and closed at $0.39.
This is a +6.45% increase from the previous day's closing price.
A total volume of 84,273,355 shares were traded at the close of the day’s session.
In the last one week, shares of Novo Integrated Sciences Inc have increased by +81.21%.
Novo Integrated Sciences Inc's Key Ratios
Novo Integrated Sciences Inc has a market cap of $57.68 million, indicating a price to book ratio of 0.172 and a price to sales ratio of 0.3565.
In the last 12-months Novo Integrated Sciences Inc’s revenue was $1.12 million with a gross profit of $3.82 million and an EBITDA of $-7970003. The EBITDA ratio measures Novo Integrated Sciences Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Novo Integrated Sciences Inc’s operating margin was -921.86% while its return on assets stood at -12.04% with a return of equity of -92.43%.
In Q1.6666666666667, Novo Integrated Sciences Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 76.2%.
Novo Integrated Sciences Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $-0.81 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Novo Integrated Sciences Inc’s profitability.
Novo Integrated Sciences Inc stock is trading at a EV to sales ratio of 0.7195 and a EV to EBITDA ratio of -4.2118. Its price to sales ratio in the trailing 12-months stood at 0.3565.
Novo Integrated Sciences Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $35.75 million
- Total Liabilities
- $6.21 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $18870
- Dividend Payout Ratio
- 0%
Novo Integrated Sciences Inc ended 2024 with $35.75 million in total assets and $0 in total liabilities. Its intangible assets were valued at $35.75 million while shareholder equity stood at $26.57 million.
Novo Integrated Sciences Inc ended 2024 with $0 in deferred long-term liabilities, $6.21 million in other current liabilities, 144857.00 in common stock, $-63872587.00 in retained earnings and $7.54 million in goodwill. Its cash balance stood at $464011.00 and cash and short-term investments were $464011.00. The company’s total short-term debt was $2,318,939 while long-term debt stood at $64946.00.
Novo Integrated Sciences Inc’s total current assets stands at $4.00 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $2.37 million compared to accounts payable of $1.90 million and inventory worth $938940.00.
In 2024, Novo Integrated Sciences Inc's operating cash flow was $0 while its capital expenditure stood at $18870.
Comparatively, Novo Integrated Sciences Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $0.39
- 52-Week High
- $1.418
- 52-Week Low
- $0.069
- Analyst Target Price
- $
Novo Integrated Sciences Inc stock is currently trading at $0.39 per share. It touched a 52-week high of $1.418 and a 52-week low of $1.418. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $0.15 and 200-day moving average was $0.15 The short ratio stood at 0.21 indicating a short percent outstanding of 0%.
Around 889.8% of the company’s stock are held by insiders while 46.9% are held by institutions.
Frequently Asked Questions About Novo Integrated Sciences Inc
Similar Industry Stocks (Medical Care Facilities)
Most Active
Top Gainers
Top Losers
About
Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary health care related products and services. It operates through two segments, Healthcare Services and Product Sales. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline testing, trauma sensitive yoga and meditation for concussion-acquired brain injury and occupational stress-PTSD, women’s pelvic health program, sports medicine therapy, assistive devices, dietitian, holistic nutrition, fall prevention education, sports team conditioning program, and private personal training services. It also engages in the assessment, diagnosis, treatment, pain management, rehabilitation, education, and prevention of various orthopedic, musculoskeletal, sports injury, and neurological conditions across various demographics, including pediatric, adult, and geriatric populations. In addition, the company offers eldercare physiotherapy services, such as long-term care homes, retirement homes, community-based home care physiotherapy, community-based group exercise classes and fall prevention programs, and community-based outpatient clinics; and elderly occupational therapy services for retirement home and community, and long-term care sectors. Further, it offers medical technology services, such as telemedicine and remote patient monitoring; and develops and distributes personalized health and wellness product solutions. The company operates corporate-owned clinics. The company is based in Bellevue, Washington. Novo Integrated Sciences, Inc. is a subsidiary of ALMC-ASAP Holdings, Inc.